SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Driving innovation in biotechnology: Podcast guest Dr. Mimi Roy shapes the future of human health

SelectScience

Dr. Mimi Roy's commitment to scientific excellence and her work developing gene therapies for rare diseases

17 Jul 2023
Georgina Wynne Hughes
Editorial Assistant

Editorial article

Dr. Mimi Roy, Senior Vice President of Technical Operations at Grace Science LLC

Dr. Sushmita 'Mimi' Roy is a distinguished scientist and biotechnology expert known for her significant contributions in chemistry, biochemistry, and analytical sciences. With a diverse career in academia, industry, entrepreneurship, and leadership, Roy specializes in proteomics, metabolomics, and biologics.

Roy's academic journey began with a Bachelor's degree in Chemistry from St. Stephen's College, Delhi, where she developed an assay to measure glutathione levels in whole blood. She then pursued a Master's degree in Biochemistry at the University of Sydney, focusing on NMR studies of metabolites in human blood and cells.

Continuing her studies in the United States, Roy obtained a Ph.D. in Chemistry from Princeton University, where she specialized in protein design and characterization. Her doctoral research involved protein overexpression, purification, and biophysical characterization using advanced analytical techniques.

As a post-doctoral fellow at The Scripps Research Institute, studying DNA design with Peter Schultz, Roy contributed to pioneering research on expanding the genetic code through unnatural DNA base. Her work involved DNA sequencing, polymerase kinetics characterization, and high-throughput screenings of polymerase libraries.

Roy then moved into industry in 2000, where she made significant contributions while working as a Scientist at SurroMed Inc. and Biomarker Discovery Sciences, PPD Inc., focusing on technology and platform development for proteomics, metabolomics, and CNS proteomics.

Roy then assumed the role of Senior Director and USA Site Head at Caprion Biosciences Inc. from 2010 to 2014. In this role, Roy managed the company's operations in the US, overseeing technical and business operations, and successfully led projects supported by multi-million dollar contracts and grants from esteemed institutions including the National Cancer Institute and the NIH. Roy's work primarily focused on developing methodologies, studying biological and preanalytical variation, and unraveling proteomic changes in cancer and neurodegeneration.

In 2014, Roy co-founded Sensibrace Technologies Inc. and invented an electronic medical device to correct hand posture, addressing carpal tunnel syndrome. Roy also founded iON Bioservices LLC in the same year, providing analytical services in biologics development, including mass spectrometry, proteomics, and metabolomics.

In 2015, Roy joined BioMarin Pharmaceutical Inc., where she served as the Executive Director of Analytical Chemistry, overseeing assay development and characterization for therapeutic proteins, gene therapies, and small molecules. She played a pivotal role in regulatory submissions, analytics support, and managed technical groups in various analytical areas.

In 2021, Roy established Ion Bio Enterprises LLC, offering consulting services in gene therapy, pharmaceutical development, analytical science, and proteomics. She later served as the Vice President and Head of Process R&D at Resilience, leading CMC technology development for AAV gene therapy and cell-free biologics production.

Currently, Roy holds the position of Senior Vice President of Technical Operations at Grace Science, LLC. Her work focuses on the Chemistry, Manufacturing, and Control (CMC) of viral vectors used in Phase 1/2/3 clinical trials for ultra-rare and rare diseases, with a specific focus on NGly-1 deficiency. She is a respected leader in the field of biotechnology and holds expertise as an inventor in AAV gene therapy.

SelectScience® CEO, Kerry Parker, recently spoke with Dr. Mimi Roy about her work developing gene therapies for ultra rare diseases in “The Accelerating Science Podcast by SelectScience”. To learn more about how gene therapies and viral vectors work and the accelerated impact of AI and mass spectrometry in scientific progress, listen to our podcast today.

Listen to “The future of rare disease therapies: Dr. Mimi Roy explores gene therapies, AI, and mass spectrometry” here!

Links

SelectScienceCompany website

Tags

ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. Artificial Intelligence / Machine LearningArtificial intelligence (AI) and machine learning (ML) are transformative technologies used to analyze complex data, identify patterns, and make data-driven predictions across diverse scientific fields. Automate the analysis of large or complex data sets using AI algorithms and leverage machine learning models to improve diagnostics, accelerate drug discovery, and refine experimental design. Discover the best AI/ML software, platforms, and analytical tools in our peer-reviewed product directory: compare features, read customer reviews, and request pricing directly from manufacturers.MetabolomicsMetabolomics is the study of small metabolites (the intermediates and products of metabolism). It involves the identification and quantification of cellular metabolites using analytical technologies such as GC, HPLC, NMR, and LC/MS.BiologicsBiologics are medical products derived from living organisms, including vaccines, gene therapies, and monoclonal antibodies. These treatments are key to modern healthcare, especially in oncology and autoimmune diseases. Explore biologics research tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.BiotechnologyBiotechnology is the use of biological processes, organisms, or systems in the production of products and services. It spans a wide range of applications, including healthcare, agriculture, and environmental management. Browse our peer-reviewed product directory to find the best biotechnology tools, compare products, check reviews, and get pricing directly from manufacturers.Gene TherapyGene therapy is a technique that modifies or replaces genes within an individual's cells to treat or prevent diseases. This approach holds potential for curing genetic disorders, cancers, and certain viral infections. Advances in gene editing technologies like CRISPR are driving the growth of gene therapy. Explore gene therapy tools and technologies in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.

Related articles

Driving innovation in biotechnology: Podcast guest Dr. Mimi Roy shapes the future of human health